Glatiramer injection and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Glatiramer injection and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer injection-Tafenoquine Succinate (Arakoda)
- Glatiramer injection-Tafenoquine Succinate (Krintafel)
- Glatiramer injection-Tafinlar
- Glatiramer injection-Tafluprost
- Glatiramer injection-Tafluprost ophthalmic
- Glatiramer injection-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-Glatiramer Subcutaneous
- Tafenoquine (Prevention of Malaria Relapse)-Glatopa
- Tafenoquine (Prevention of Malaria Relapse)-Glatopa injection
- Tafenoquine (Prevention of Malaria Relapse)-Glecaprevir and pibrentasvir
- Tafenoquine (Prevention of Malaria Relapse)-Gleevec
- Tafenoquine (Prevention of Malaria Relapse)-Glenmax PEB DM